Northern Trust Corp Verrica Pharmaceuticals Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Northern Trust Corp holds 219,104 shares of VRCA stock, worth $1.74 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

219,104

Previous 190,675 14.91%

Holding current value

$1.74 Million

Previous $1.39 Million 25.25%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$7.95 - $7.95 $226,010 - $226,010	28,429 Added 14.91%	219,104 $1.74 Million
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.56 $47,396 - $76,929	-8,047 Reduced 4.05%	190,675 $1.39 Million
Q1 2024 May 14, 2024	SELL	$4.74 - $6.81 $753 - $1,082	-159 Reduced 0.08%	198,722 $1.18 Million
Q4 2023 Feb 13, 2024	BUY	$2.93 - $7.32 $33,410 - $83,469	11,403 Added 6.08%	198,881 $1.46 Million
Q3 2023 Nov 13, 2023	SELL	$3.75 - $7.46 $6,288 - $12,510	-1,677 Reduced 0.89%	187,478 $727,000
Q2 2023 Aug 11, 2023	BUY	$5.32 - $6.79 $732,771 - $935,247	137,739 Added 267.89%	189,155 $1.09 Million
Q1 2023 May 15, 2023	BUY	$2.88 - $8.51 $10,376 - $30,661	3,603 Added 7.54%	51,416 $334,000
Q4 2022 Feb 13, 2023	SELL	$2.09 - $3.39 $695 - $1,128	-333 Reduced 0.69%	47,813 $131,000
Q3 2022 Nov 14, 2022	BUY	$2.17 - $4.3 $14,532 - $28,797	6,697 Added 16.16%	48,146 $141,000
Q2 2022 Aug 12, 2022	SELL	$1.81 - $8.93 $171,057 - $843,947	-94,507 Reduced 69.51%	41,449 $80,000
Q1 2022 May 13, 2022	SELL	$7.59 - $9.49 $29,456 - $36,830	-3,881 Reduced 2.78%	135,956 $1.1 Million
Q4 2021 Feb 08, 2022	SELL	$9.1 - $13.36 $5,605 - $8,229	-616 Reduced 0.44%	139,837 $1.28 Million
Q3 2021 Nov 15, 2021	SELL	$9.55 - $13.96 $61,740 - $90,251	-6,465 Reduced 4.4%	140,453 $1.76 Million
Q2 2021 Aug 13, 2021	SELL	$9.77 - $15.33 $48,820 - $76,604	-4,997 Reduced 3.29%	146,918 $1.66 Million
Q1 2021 May 12, 2021	SELL	$10.51 - $17.46 $272,766 - $453,139	-25,953 Reduced 14.59%	151,915 $2.3 Million
Q4 2020 Feb 11, 2021	SELL	$7.41 - $12.63 $72,195 - $123,054	-9,743 Reduced 5.19%	177,868 $2.05 Million
Q3 2020 Nov 16, 2020	BUY	$6.16 - $10.3 $426,000 - $712,306	69,156 Added 58.38%	187,611 $1.45 Million
Q2 2020 Aug 14, 2020	SELL	$9.02 - $15.12 $299,491 - $502,029	-33,203 Reduced 21.89%	118,455 $1.3 Million
Q1 2020 May 14, 2020	BUY	$7.14 - $16.86 $75,134 - $177,417	10,523 Added 7.46%	151,658 $1.66 Million
Q4 2019 Feb 14, 2020	BUY	$13.08 - $17.43 $62,679 - $83,524	4,792 Added 3.51%	141,135 $2.24 Million
Q3 2019 Nov 13, 2019	BUY	$8.65 - $14.81 $216,959 - $371,464	25,082 Added 22.54%	136,343 $2.01 Million
Q2 2019 Aug 13, 2019	BUY	$7.1 - $11.62 $28,747 - $47,049	4,049 Added 3.78%	111,261 $1.29 Million
Q1 2019 May 13, 2019	BUY	$7.95 - $14.07 $319,462 - $565,388	40,184 Added 59.95%	107,212 $1.16 Million
Q4 2018 Feb 12, 2019	BUY	$6.75 - $16.12 $31,650 - $75,586	4,689 Added 7.52%	67,028 $546,000
Q3 2018 Nov 14, 2018	BUY	$13.94 - $19.88 $869,005 - $1.24 Million	62,339 New	62,339 $1.01 Million

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Verrica Pharmaceuticals Inc. Transaction History